Regulatory Landscape and FDA Approvals: The biopharmaceutical industry is heavily influenced by regulatory changes and the speed and success of drug approvals by agencies like the FDA. Favorable or unfavorable regulatory environments can significantly impact development costs, market access, and time to market for new therapies.

Healthcare Spending and Reimbursement Policies: As a company commercializing drugs, Catalyst Pharmaceuticals' revenue is sensitive to healthcare spending trends, insurance coverage, and reimbursement policies, especially for high-cost rare disease treatments.

Competition and Pipeline Development and Patent Protection: The success of biopharmaceutical companies depends on their ability to develop and commercialize novel drugs. Competition from other companies developing similar treatments and the strength of Catalyst's own drug pipeline (e.g., FIRDAPSE, AGAMREE, FYCOMPA) are crucial. Patent litigation and exclusivity also play a role.